TEROL LA (Detrol LA)2 mg – 30 tablet


Each Terol La contains 2 mg Tolterodine 30 tablets a box, it is a treatment for an overactive bladder characterized by frequent urination.

ATC Classification: G04BD07
Active Ingrediant: Tolterodine Tartrate
Generic Name: TEROL LA
Manufacturer: Cipla Limited
Strength: 2 mg
Dosage Type: Capsule
Packaging Type: Foil
Contains: 30 Cap

Tolterodine Tartrate Information


tole TER oh deen


What is this drug used for?

• It is used to treat an overactive bladder.

Frequently reported side effects of this drug

• Dizziness

• Fatigue

• Headache

• Abdominal pain

• Constipation

• Dry mouth

• Dry eyes

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Unable to pass urine

• Vision changes

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.


Medication Safety Issues

Sound-alike/look-alike issues:

Tolterodine may be confused with fesoterodine, tolcapone

Detrol may be confused with Ditropan

Geriatric Patients: High-Risk Medication:

Beers Criteria: Tolterodine is identified in the Beers Criteria as a potentially inappropriate medication in patients 65 years and older due to its strong anticholinergic properties (Beers Criteria [AGS 2019]).


Storage and Stability

Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light.


Adverse Reactions

As reported with immediate release tablet, unless otherwise specified.

Cardiovascular: Chest pain

Central nervous system: Anxiety (extended release capsules), dizziness (immediate and extended release), drowsiness (immediate and extended release), fatigue (immediate and extended release), headache (immediate and extended release)

Dermatologic: Xeroderma

Endocrine & metabolic: Weight gain

Gastrointestinal: Abdominal pain (immediate and extended release), constipation (immediate and extended release), diarrhea, dyspepsia (immediate and extended release), xerostomia (more common with immediate release tablets)

Genitourinary: Dysuria (immediate and extended release)

Infection: Infection

Neuromuscular & skeletal: Arthralgia

Ophthalmic: Xerophthalmia (immediate and extended release), visual disturbance (immediate and extended release)

Respiratory: Bronchitis, flu-like symptoms, sinusitis (extended release)

Rare but important or life-threatening: Anaphylaxis, angioedema, confusion, dementia (aggravated), disorientation, hallucination, memory impairment, palpitations, peripheral edema, prolonged Q-T interval on ECG, tachycardia

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


Dosage Type

Packaging Type




There are no reviews yet.

Be the first to review “TEROL LA (Detrol LA)2 mg – 30 tablet”

Your email address will not be published. Required fields are marked *